Which Emerging Trends Are Driving The Exocrine Pancreatic Insufficiency Market Toward $3.59 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Exocrine Pancreatic Insufficiency Market Expected To Grow In Terms Of Size?
The market for exocrine pancreatic insufficiency has seen a robust expansion in the past few years. The market is projected to rise from $2.59 billion in 2024 to $2.75 billion in 2025, at a compound annual growth rate (CAGR) of 6.4%. Factors driving growth during the historic period include a rise in awareness and diagnosis, escalated incidences of digestive disorders, an aging population, declining pancreatic function, and an increase in gastrointestinal surgeries.
Strong expansion is projected for the exocrine pancreatic insufficiency market over the next few years, with its value predicted to reach $3.59 billion by 2029, representing a compound annual growth rate (CAGR) of 6.9%. This growth trajectory in the forecasted period can be ascribed to the sustained promotion of awareness and screening programs, the growth of the elderly population, the escalating prevalence of chronic diseases, enhancements in patients’ healthcare accessibility, and research and development efforts in digestive medical care. The forecast period will also see major trends such as telehealth and online health solutions, joint research endeavors, attention on pediatric exocrine pancreatic insufficiency, and advancements in regulation and accelerated approval processes. The burgeoning progress in healthcare infrastructure and market development in emerging economies are likewise key growth drivers.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13107&type=smp
Which Key Factors Are Fueling Growth In The Exocrine Pancreatic Insufficiency Market?
The upswing in persistent illnesses is projected to stimulate the expansion of the exocrine pancreatic insufficiency market moving forward. These chronic illnesses are enduring medical issues that typically last for three months or more. The continuous existence of these illnesses heightens the likelihood of secondary complications, like exocrine pancreatic insufficiency, fueling the essential management of these chronic conditions through medical interventions and therapies. Consequently, this can result in a prolonged lifespan for those afflicted with these conditions. As an example, in September 2023, the World Health Organization (WHO), a specialized branch of the United Nations located in Switzerland, highlighted that 41 million fatalities occur yearly, with a significant 74% tied to non-communicable diseases or chronic illnesses globally. Thus, the surging prevalence of chronic diseases will spur the growth of the exocrine pancreatic insufficiency market.
How Is The Exocrine Pancreatic Insufficiency Market Categorized Across Applications And Types?
The exocrine pancreatic insufficiencymarket covered in this report is segmented –
1) By Treatment: Nutritional Management; Pancreatic Enzyme Replacement Therapy (PERT); Other Treatments
2) By Diagnosis: Imaging Tests; Computed Tomography (CT) Scan; Abdominal Ultrasound; Secretin Pancreatic Function Test; Fecal Fat Test; Fecal Elastase Test (FE-1); Other Types
3) By Symptoms: Abdominal Pain; Constipation; Diarrhea; Fatty Stools; Weight Loss; Other Symptoms
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End Users: Hospitals; Specialty Clinics; Homecare
Subsegments:
1) By Nutritional Management: Dietary Modifications; Nutritional Supplements
2) By Pancreatic Enzyme Replacement Therapy (PERT): Enteric-Coated Capsules; Non-Enteric-Coated Capsules; Powder Formulations
3) By Other Treatments: Medications; Surgical Interventions; Supportive Therapies
How Are Industry Trends Steering The Expansion Of The Exocrine Pancreatic Insufficiency Market?
Leading businesses in the exocrine pancreatic insufficiency market are putting emphasis on the establishment of patient advocacy groups such as comprehensive nutritional counseling to supply all-encompassing nutritional advice and assistance. These endeavors are targeted at enhancing awareness, teaching, and control of the condition amongst affected individuals. A comprehensive nutritional guidance is an all-encompassing method that customizes dietary suggestions based on the specific requirements, health issues and lifestyle of an individual. This method stresses on education, planning meals, and enduring practices to improve overall health. For example, in June 2024, Nestlé Health Science, a leading nutrition company based in Switzerland, introduced a GLP-1 nutrition support platform. Nestlé Health Science’s GLP-1 nutrition support platform provides customized nutritional resources and expert advice for those using GLP-1 medications with a focus on maintaining muscle health, improving gut health and uplifting overall wellness. The platform is intended to fortify users in their journey of managing weight by addressing unique dietary requirements and encouraging community support.
Which Firms Are Making The Biggest Impact In The Exocrine Pancreatic Insufficiency Market?
Major companies operating in the exocrine pancreatic insufficiency market report are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Janssen Pharmaceuticals Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Medtronic PLC, Eli Lilly and Company, Gilead Sciences Inc., Nestle Health Science S.A., Allergan PLC, Chiesi Farmaceutici S.p.A., Wockhardt Ltd., Amryt Pharma PLC, Codexis Inc., Nordmark Arzneimittel GmbH & Co. KG, Aimmune Therapeutics Inc., Digestive Care Inc., Enzymedica Inc., Vivus Inc., Alcresta Therapeutics Inc., Cilian AG, Perseo Pharma AG, Enzyme Development Corporation, First Wave BioPharma Inc., Synspira Therapeutics
Access The Complete Report Here:
Which Region Holds The Greatest Opportunity For Exocrine Pancreatic Insufficiency Market Expansion?
North America was the largest region in the exocrine pancreatic insufficiency market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the exocrine pancreatic insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13107&type=smp
Browse Through More Reports Similar to the Global Exocrine Pancreatic Insufficiency Market 2025, By The Business Research Company
Exocrine Pancreatic Insufficiency Epi Therapeutics And Diagnostics Global Market Report 2025
Mineral And Bone Disorder Treatment Global Market Report 2025
Home Infusion Therapy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/home-infusion-therapy-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
